References
- Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1999;37:731–751.
- Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial. 2007;20(3):217–219.
- Burkitt JM, Haskins SC, Aldrich J, et al. Effects of oral administration of a commercial activated charcoal suspension on serum osmolality and lactate concentration in the dog. J Vet Intern Med. 2005;19(5):683–686.
- . Yu DK, Elmquist WF, Sawchuk RJ. Pharmacokinetics of propylene glycol in humans during multiple dosing regimens. J Pharm Sci. 1985;74(8):876–879.
- . Miremont Salamé G, Théophile H, Haramburu F, et al. Causality assessment in pharmacovigilance: The French method and its successive updates. Therapie. 2016;71(2):179–186.